Trial · NCT00414466
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 12 of 12
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Changes in a Pain Rating Scale After 3 Weeks of Blinded Treatment. | 1 Placebo | 0.48 | Standard Deviation 1.52 | Scores on a scale | |
| Changes in a Pain Rating Scale After 3 Weeks of Blinded Treatment. | 2 Gabapentin Low | 0.40 | Standard Deviation 1.33 | Scores on a scale | |
| Changes in a Pain Rating Scale After 3 Weeks of Blinded Treatment. | 3 Gabapentin Medium | 0.10 | Standard Deviation 0.99 | Scores on a scale | |
| Changes in a Pain Rating Scale After 3 Weeks of Blinded Treatment. | 4 Gabapentin High | -0.02 | Standard Deviation 1.11 | Scores on a scale | |
| Responder Analysis Between Active Treatment and Placebo Groups. | 1 Placebo | 4 | Participants | ||
| Responder Analysis Between Active Treatment and Placebo Groups. | 2 Gabapentin Low | 4 | Participants | ||
| Responder Analysis Between Active Treatment and Placebo Groups. | 3 Gabapentin Medium | 1 | Participants | ||
| Responder Analysis Between Active Treatment and Placebo Groups. | 4 Gabapentin High | 2 | Participants | ||
| Number of Participants With Treatment-emergent Adverse Events | 1 Placebo | 40 | Participants | ||
| Number of Participants With Treatment-emergent Adverse Events | 2 Gabapentin Low | 32 | Participants | ||
| Number of Participants With Treatment-emergent Adverse Events | 3 Gabapentin Medium | 37 | Participants | ||
| Number of Participants With Treatment-emergent Adverse Events | 4 Gabapentin High | 36 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00414466/results